Cyclacel Pharmaceuticals, Inc. 6% Convertible Preferred Stock Share Price
NASDAQ: CYCCP$0.00
+0.00 (0.00%) Cyclacel Pharmaceuticals, Inc. 6% Convertible Preferred Stock Stock Performance
Cyclacel Pharmaceuticals, Inc. 6% Convertible Preferred Stock Share Price Chart
$0.00$0.00
L
H
Cyclacel Pharmaceuticals, Inc. 6% Convertible Preferred Stock Quarterly Profit & Loss
All figures in USD
Cyclacel Pharmaceuticals, Inc. 6% Convertible Preferred Stock Annual Profit & Loss
All figures in USD
About Cyclacel Pharmaceuticals, Inc. 6% Convertible Preferred Stock
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.
Cyclacel Pharmaceuticals, Inc. 6% Convertible Preferred Stock Historical Returns
| Month | Open | Close | Change % |
|---|
CYCCP Share Price FAQs
What is Cyclacel Pharmaceuticals, Inc. 6% Convertible Preferred Stock share price today?
Cyclacel Pharmaceuticals, Inc. 6% Convertible Preferred Stock share price today is $0.00 as on September 20, 2026 at 7:39 pm IST.
What is the 52 week high and 52 week low of Cyclacel Pharmaceuticals, Inc. 6% Convertible Preferred Stock stock?
52 week high/low data for Cyclacel Pharmaceuticals, Inc. 6% Convertible Preferred Stock is currently unavailable.
What is CYCCP's net income for the last quarter?
CYCCP's net income for the last quarter is -0.00B USD.
Can I buy CYCCP shares in India?
Yes. You can buy CYCCP in India by opening an international trading account.